8-K: Cross Country Healthcare Reports Mixed Q2 2024 Results Amidst Challenging Market

Cross Country Healthcare's second quarter results show a significant year-over-year revenue decline, but some positive signs in physician staffing and cash flow.

Summary

• Cross Country Healthcare announced its financial results for the second quarter of 2024, revealing a challenging period with a 37% year-over-year decrease in revenue to $339.8 million.
• The company experienced a net loss of $16.1 million, a significant drop compared to the $21.3 million profit in the same quarter last year.
• Adjusted EBITDA was $14.2 million, a 68% decrease year-over-year, and the adjusted EPS was $0.10, down from $0.69 in the prior year.
• Despite the overall decline, the company saw positive growth in physician staffing revenue, which increased by 7% year-over-year and 3% sequentially.
• Cash flow from operations was strong at $82.4 million, driven by improved collections, and the company repurchased approximately 980,000 shares for $14.9 million.
• The company's balance sheet remains strong with $70 million in cash and no debt as of June 30, 2024.
• For the six months ended June 30, 2024, consolidated revenue was $718.9 million, a decrease of 38% year-over-year, and the net loss was $13.4 million.

Sentiment

Score: 4

Explanation: The document presents a mixed picture with significant year-over-year declines in revenue and profitability, but some positive signs in cash flow and physician staffing. The overall tone is cautious, reflecting the challenging market conditions.

Positives

• Physician staffing revenue saw a 7% year-over-year and 3% sequential increase.
• The company generated $82.4 million in cash flow from operations in Q2 2024.
• Days Sales Outstanding improved by 7 days year-over-year and 18 days sequentially.
• The company maintains a strong balance sheet with $70 million in cash and no debt.
• The company repurchased approximately 980,000 shares of common stock for $14.9 million.

Negatives

• Consolidated revenue decreased by 37% year-over-year and 10% sequentially.
• The company reported a net loss of $16.1 million, compared to a profit of $21.3 million in the same quarter last year.
• Adjusted EBITDA decreased by 68% year-over-year.
• Adjusted EPS decreased to $0.10 from $0.69 in the prior year.
• Nurse and Allied Staffing revenue decreased by 41% year-over-year and 12% sequentially.
• Contribution income for Nurse and Allied Staffing decreased significantly year-over-year and sequentially.

Risks

• The company is facing a challenging environment for core nurse and allied staffing.
• There is a risk of continued revenue decline in the Nurse and Allied Staffing segment.
• The company's financial performance is subject to macroeconomic conditions, including inflation and interest rates.
• The company's ability to attract and retain qualified healthcare personnel is a risk.
• The company's future performance is subject to various risks, including cyber security incidents and government regulations.

Future Outlook

The company expects Q3 2024 revenue to be between $305 million and $315 million, a 29% to 31% decrease year-over-year, and adjusted EBITDA to be between $10 million and $13 million, a 52% to 63% decrease year-over-year. Adjusted EPS is expected to be between $0.08 and $0.12.

Management Comments

• John A. Martins, President and Chief Executive Officer, stated that the second quarter results were in line with expectations, reflecting the company's ability to execute in a challenging environment.
• He also mentioned being encouraged by a rise in demand for services and cautiously optimistic about nearing an inflection point in growing the number of professionals on assignment.
• He highlighted the strong pipeline for new business driven by the Intellify platform.

Industry Context

The healthcare staffing industry is currently facing challenges, including decreased demand for travel nurses and allied health professionals, which is reflected in Cross Country Healthcare's results. However, the company's physician staffing segment is showing resilience, which aligns with the broader trend of increased demand for physician services.

Comparison to Industry Standards

• Cross Country Healthcare's revenue decline of 37% year-over-year is significant and likely worse than some of its competitors who have diversified revenue streams.
• Competitors like AMN Healthcare have also reported revenue declines, but the magnitude of the decline varies, suggesting that Cross Country may be more heavily impacted by the current market conditions.
• The company's adjusted EBITDA margin of 4.2% is lower than historical averages for the industry, indicating a potential need for cost management improvements.
• The strong cash flow from operations is a positive sign, but it needs to be sustained to support future growth and investments.

Stakeholder Impact

• Shareholders are negatively impacted by the decrease in revenue and profitability.
• Employees may be affected by the company's cost-saving initiatives.
• Customers may experience changes in service delivery due to the challenging market conditions.
• Suppliers may be impacted by the company's financial performance.

Next Steps

• The company will hold a conference call on July 31, 2024, to discuss the second quarter results.
• The company will focus on growing the number of professionals on assignment and leveraging its Intellify platform for new business.

Key Dates

Keywords

Healthcare Staffing, Nurse Staffing, Physician Staffing, Financial Results, EBITDA, EPS, Revenue, Cash Flow, Share Repurchase